Delveinsight

DECEMBER 10, 2020

Scientists at the University of Utah School of Medicine have found a way to control that autoimmune response by aiming a protein that is vital for T-cell activation. UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3. Its recent data infer that it could work for patients considered unsuited for gene therapy.

Gene Therapy 52

Gene Therapy Gene Vaccination Vaccine 52

XTalks

JANUARY 26, 2024

This technology, which allows for precise editing of DNA at specific locations, has been a major focus in the field due to its potential to directly target and modify cancer-causing genes. By editing these genes, researchers can effectively neutralize their cancer-promoting effects.

Research 118

Research Gene Editing Gene Genetics 118

The Pharma Data

FEBRUARY 21, 2022

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

Radiology 52

Radiology Cardiology Development Production 52

The Pharma Data

MAY 3, 2021

Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims ( STAT ). How the FDA’s ‘master plan’ will affect NIH funding for digital medicine projects ( STAT ). Avrobio changes course after FDA closes path for speedy gene therapy approval ( BioPharmaDive ).

Gene Therapy 52

Gene Therapy Vaccination Vaccine Bioequivalency 52

pharmaphorum

APRIL 7, 2021

billion-plus alliance with UK biotech Artios Pharma to develop precision medicines for cancer. Novartis has made radioligands one of four pillars of its cancer business, along with cell and gene therapy, targeted drugs and immunotherapeutics, and has been steadily bolting on assets to expand its pipeline in this area.

DNA 52

DNA Licensing Licensing Gene Therapy 52

The Pharma Data

AUGUST 5, 2021

Bayer recently formed its own cell and gene therapy platform as part of its transformation strategy for Pharmaceuticals. The platform already has potentially ground-breaking medical innovations in clinical development, such as a therapy for the treatment of Parkinson’s. Pharmaceuticals raises sales and earnings.

Sales 52

Sales Production Gene Therapy Allergies 52

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Targeting the CNS directly has been successful in modern medicine. Next Steps for Targeted CNS Delivery.

Trials 83

Trials Drug Delivery Drugs Gene 83